3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Gynecologic
1
Breast
1
Conditions
Neoplastic Syndromes, Hereditary
1
Neoplasms
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Interventions
pembrolizumab
45
Paclitaxel
45
Carboplatin
39
Magnetic Resonance Spectroscopy
28
olaparib
27
Specimen Handling
26
Cisplatin
24
Bevacizumab
20
Nivolumab
18
Taxes
17
Biopsy
16
Gemcitabine
13
Cyclophosphamide
13
durvalumab
12
Immunoglobulin G
11
Doxorubicin
11
Disulfides
11
Surveys and Questionnaires
10
niraparib
9
liposomal doxorubicin
9
dostarlimab
9
Radiotherapy
8
Brachytherapy
8
lenvatinib
7
fludarabine
7
atezolizumab
7
Letrozole
7
Docetaxel
7
cediranib
6
Platinum
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
High-Throughput Nucleotide Sequencing
×
Gynecologic
×
Clear all
NCT04261972
2026-01-14
CHARM1
University Health Network, Toronto
Active not recruiting
1,416 enrolled